| Childhood acute lymphoblastic leukemia: progress through collaboration CH Pui, JJ Yang, SP Hunger, R Pieters, M Schrappe, A Biondi, A Vora, ... Journal of Clinical Oncology 33 (27), 2938, 2015 | 952 | 2015 |
| Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells W Qasim, H Zhan, S Samarasinghe, S Adams, P Amrolia, S Stafford, ... Science translational medicine 9 (374), eaaj2013, 2017 | 948 | 2017 |
| A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial R Pieters, M Schrappe, P De Lorenzo, I Hann, G De Rossi, M Felice, ... The Lancet 370 (9583), 240-250, 2007 | 765 | 2007 |
| Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial A Vora, N Goulden, R Wade, C Mitchell, J Hancock, R Hough, ... The lancet oncology 14 (3), 199-209, 2013 | 514 | 2013 |
| Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial AV Moorman, HM Ensor, SM Richards, L Chilton, C Schwab, SE Kinsey, ... The lancet oncology 11 (5), 429-438, 2010 | 506 | 2010 |
| Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice E Gluckman, V Rocha, W Arcese, G Michel, G Sanz, KW Chan, ... Experimental hematology 32 (4), 397-407, 2004 | 503 | 2004 |
| Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR S Ghorashian, AM Kramer, S Onuoha, G Wright, J Bartram, R Richardson, ... Nature medicine 25 (9), 1408-1414, 2019 | 465 | 2019 |
| Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial CD Mitchell, SM Richards, SE Kinsey, J Lilleyman, A Vora, TOB Eden, ... British journal of haematology 129 (6), 734-745, 2005 | 413 | 2005 |
| Pharmacokinetics and safety of intravenous voriconazole in children after single-or multiple-dose administration TJ Walsh, MO Karlsson, T Driscoll, AG Arguedas, P Adamson, ... Antimicrobial agents and chemotherapy 48 (6), 2166-2172, 2004 | 405 | 2004 |
| Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label … A Biondi, M Schrappe, P De Lorenzo, A Castor, G Lucchini, V Gandemer, ... The lancet oncology 13 (9), 936-945, 2012 | 370 | 2012 |
| Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute … A Vora, N Goulden, C Mitchell, J Hancock, R Hough, C Rowntree, ... The lancet oncology 15 (8), 809-818, 2014 | 336 | 2014 |
| Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials R Ramanujachar, S Richards, I Hann, A Goldstone, C Mitchell, A Vora, ... Pediatric blood & cancer 48 (3), 254-261, 2007 | 300 | 2007 |
| Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group TD Buitenkamp, S Izraeli, M Zimmermann, E Forestier, NA Heerema, ... Blood, The Journal of the American Society of Hematology 123 (1), 70-77, 2014 | 285 | 2014 |
| Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003 D O’Connor, J Bate, R Wade, R Clack, S Dhir, R Hough, A Vora, ... Blood, The Journal of the American Society of Hematology 124 (7), 1056-1061, 2014 | 260 | 2014 |
| Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21) AV Moorman, SM Richards, HM Robinson, JC Strefford, BES Gibson, ... Blood 109 (6), 2327-2330, 2007 | 260 | 2007 |
| Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia CJ Harrison, AV Moorman, ZJ Broadfield, KL Cheung, RL Harris, ... British journal of haematology 125 (5), 552-559, 2004 | 259 | 2004 |
| Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies R Benjamin, C Graham, D Yallop, A Jozwik, OC Mirci-Danicar, G Lucchini, ... The Lancet 396 (10266), 1885-1894, 2020 | 258 | 2020 |
| Outcome for children and young people with E arly T‐cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003 K Patrick, R Wade, N Goulden, C Mitchell, AV Moorman, C Rowntree, ... British journal of haematology 166 (3), 421-424, 2014 | 252 | 2014 |
| Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options U Fischer, M Forster, A Rinaldi, T Risch, S Sungalee, HJ Warnatz, ... Nature genetics 47 (9), 1020-1029, 2015 | 239 | 2015 |
| A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia AV Moorman, A Enshaei, C Schwab, R Wade, L Chilton, A Elliott, ... Blood, The Journal of the American Society of Hematology 124 (9), 1434-1444, 2014 | 235 | 2014 |
